This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
Co-Diagnostics, Inc (CODX) is a leading diagnostics & research business based in the US. It opened the day at USD$10.9 after a previous close of USD$10.97. During the day the price has varied from a low of USD$10.65 to a high of USD$11.03. The latest price was USD$10.96 (25 minute delay). Co-Diagnostics is listed on the NASDAQ and employs 39 staff. All prices are listed in US Dollars.
About our promoted products: Our 'promoted' products are presented as a result of a commercial advertising arrangement or to highlight a particular feature. Promoted products are not a recommendation, an indication a product is the best in its category, nor represent all products in the market. It is important to compare your options and find the right product for you. Some of our promoted products are CFD providers. CFDs are complex financial products and traders are at high-risk of losing all of or more than their initial investment
|52-week range||USD$0.88 - USD$29.99|
|50-day moving average||USD$12.9739|
|200-day moving average||USD$15.951|
|Wall St. target price||USD$30.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.122|
|1 week (2020-11-27)||-7.82%|
|1 month (2020-11-04)||-22.93%|
|3 months (2020-09-04)||33.01%|
|6 months (2020-06-04)||-35.26%|
|1 year (2019-12-04)||974.51%|
|2 years (2018-12-04)||390.60%|
|3 years (2017-12-04)||121.41%|
|5 years (2015-11-30)||N/A|
Valuing Co-Diagnostics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Co-Diagnostics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Co-Diagnostics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Co-Diagnostics shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Co-Diagnostics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$24.1 million.
The EBITDA is a measure of a Co-Diagnostics's overall financial performance and is widely used to measure a its profitability.
There are currently 6.9 million Co-Diagnostics shares held short by investors – that's known as Co-Diagnostics's "short interest". This figure is 7.5% up from 6.5 million last month.
There are a few different ways that this level of interest in shorting Co-Diagnostics shares can be evaluated.
Co-Diagnostics's "short interest ratio" (SIR) is the quantity of Co-Diagnostics shares currently shorted divided by the average quantity of Co-Diagnostics shares traded daily (recently around 1.7 million). Co-Diagnostics's SIR currently stands at 3.98. In other words for every 100,000 Co-Diagnostics shares traded daily on the market, roughly 3980 shares are currently held short.
However Co-Diagnostics's short interest can also be evaluated against the total number of Co-Diagnostics shares, or, against the total number of tradable Co-Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Co-Diagnostics's short interest could be expressed as 0.25% of the outstanding shares (for every 100,000 Co-Diagnostics shares in existence, roughly 250 shares are currently held short) or 0.2457% of the tradable shares (for every 100,000 tradable Co-Diagnostics shares, roughly 246 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Co-Diagnostics.
Thinking about buying shares in Norwegian Air Shuttle? We explain how to do it and compare a range of providers who will give you access to global markets.
Steps to owning and managing Toyota shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing NTLA, with 24-hour and historical pricing before you buy.
Ever wondered how to buy shares in Nikola? We explain how and compare a range of providers that can give you access to many brands, including Nikola.
Steps to owning and managing Switchback Energy shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing ElectraMeccanica Vehicles shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Kandi shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Fisker shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing GM shares, with 24-hour and historical pricing before you buy.
Steps to owning and managing Virgin Galactic shares, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.